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The elTwt of 12,tetradecanoyl phorbol 13.n~.etate on the GTPase activity of Gi was invextil|ated. Treatment with TPA did not alter basal GTPa=e 
activity of membrane= or |he stimulalory effect or prosta~,landin E= (ptltatiwly via Gs), In contrast, the phorbo| c~ter markedly diminished ~timuh. 
don of GTPase by al~ents who~e receptor= are coupled to Gt such as epinephrine (:c.adrener=ic action), plntele! a¢tivatintt Etctof or thrombin. Pertus- 
~is toxin catalyzed ADP.ribo~ylation was abe decrca,,ed in membranes from TPA-treated platelets as con'~pared to the ~ontrok, It is sulll|ested 
th,tt the =Iteration in tile hormonal activation of tile OTPau activity of Oi is ~¢ondary to a perturbation in the receptor.Gi nteraction. 
Protei=~ kin=us C; Enzyme activation Gi; GTPase activity; ==.Adreno~cptor 
!. INTRODUCTION 
There is evidence that protein kinase C (PKC) can 
modulate the function of signalling elements uch as 
some receptor, G-proteins and membrane effectors 
(adenylate cyclase, phospholipase C and some ion 
channels) [1]. in platelets it has been observed that ac- 
tivation of PKC by 12-tetradecanoyl phorbol 13-acetate 
(TPA) largely impairs the GTP-dependent hormone- 
sensitive inhibitory pathway to adenylate cyclase which 
involves the inhibitory GTP-binding protein, Gi [2-6]. 
It has been shown that PKC phosphorylates Gi [3] and 
blocks its function in hormonal inhibition of adenylate 
cyclase. Interestingly, the ability of hydrolysis-resistant 
GTP analogues to inhibit adenylate cyclase is not 
altered by the treatment with "I'PA [5,6] which suggests 
that the receptor/Gi interaction rather than the 
Gi/adenylate cyclase interaction is what is altered by 
PKC. Further support for this interpretation was ob- 
tained in binding studies [6]; it was observed that in 
control platelets, approximately 75% of the receptors 
were m a high-affinity state for epinephrine and ap- 
proximately 25°70 in a low-affinity state; Gpp(NH)p 
shifted the receptor affinity towards the low-affinity 
conformation [6]. In membranes from TPA-treated 
platelets, the receptors were in the low-affinity state 
and no further decrease in affinity was induced by 
Gpp(NH)p [6]. We examined the effect of TPA on 
hormone.stimulated GTPase activity; our results in- 
dicate that stimulation of PKC markedly diminished 
the hormone-stimulated GTPase activity of Gi. 
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2. MATERIALS AND METHODS 
Blood was obtained from healthy men and women wile had taken 
~o medication during the previous 2 weeks. Platelet.rich plasma was 
obtained by centrifuBation. After a preequillbration period of 5 rain 
at 37"C, the platelets were challenged with I ~,M TPA, or vehicle for 
I rain; the platelets were centrifuged and homogenized. A crude 
membrane preparation was obtained as described by Hoffman et zd. 
GTPase activity was assayed according to Cas~el and $elinger [8], 
in a mixture containing 2 mM MgCI.,, t m~ 3.isobutyl-l-nl¢th)'l- 
xanthine, O. I mM cyclic AMP, 5 mM creatine phosphate, 1,2 mg/ml 
ere=line kinase, 0.2% bovine serum albumin, I mM dithiothreitol, 
0,1 ntM EDTA, I #M GTP, 50 mM triethanolamine-HCI, pH 7,4° 
and [~,nPJGTP (0,2 ,~Ci/tube), Tile reaction was initiated by the ad- 
dition of the membranes (10 #g of protein) and was carried out for 
l0 rain or the times indicated at 25=C in a final volume of 0.1 ml. The 
release of [~zP]Pi was determined as described by Aktories and 
Jakobs [9]. Protein was quantified by the method of Lowry et ~tl. 
[10]. ADP-ribosylation was assayed in a mixture containing 250 mM 
potassium phosphate buffer pH 7.5, 10 mM arginine, 5 mM MgCl=, 
1 mM A'rP, 10 mM thymidine, 0.'75 mM NADP, 0,1 mM GTP, I0 
#M NAP and [nP]NAD (10 ~Ci/tube), The reaction was carried out 
for 60 min at 30°C for 1 h. Pertussis toxin was activated with 20 rnM 
DTT for l0 rain at 37°C. The reacti:~, was started by the addition 
of the membranes (100/.tg); following tt :' reaction, 1 ml of phosphate 
buffer was added and the membranes were pelleted by centrifugation. 
The pellet was dissolved and subjected to SDS-PAGE. The gels were 
fixed, dried and exposed to X.ray film at -72°C [I 1]. 
tmmunoprecipitation f Gi,-, was achieved using a specific 
polyclonal antibody generated against the decapeptide corresponding 
to a Gi (KNNLKDCGLF) [13], essentially as described for Gs~ [12]. 
3. RESULTS 
Under the conditions employed, basal GTPase activi- 
ty was linear as a function of time of incubation and of 
similar magnitude in membranes from control and 
TPA-treated platelets (Fig. 1). Epinephrine (100/~M) 
and prostaglandin Et (PGEt) (1 #M) increased the rate 
of  GTPase activity (Fig. I). The effect of epinephrine 
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perlments performed in triplicate, 
was blocked by yohimbine but not by prazosin in- 
dicating the involvement of cta-adrenoceptors (data not 
shown), The effect of PGE~ was similar in magnitude 
in membranes from control or TPA.treated platelets 
but, in contrast, the action of epinephrine was greatly 
diminished in membranes from TPA-treated cells as 
compared to the controls (Fig. 1). Dose/response 
curves (Fig. 2) confirmed this finding; i.e. PGEt 
stimulated similarly and in a dose-dependent fashion 
the OTPase activity of membranes from control and 
TPA.treated platelets; epinephrine induced a dose- 
dependent GTPase activation in control membranes 
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but only indre~sed GTPase activity at the highest con- 
cemration tested (100 ~M) in membranes from TPA- 
treated cells (Fig. 2). 
The decreased activation of GTPase activity was not 
exclusive to epinephrine but common to other agents 
whose receptors interact with Gi, such as platelet ac- 
tivating factor and thrombin (Table I). 
Pertussis toxin-catalyzed ADP-ribosylation of mem- 
branes from controt and TPA-treated platelets howed 
the labeling of -41 kDa protein(s). Interestingly, in
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Fig, 2, Effect of TPA on the stimulations of GTPase activity induced 
by epinephrine or prostaglandin Ez. Membranes from control (open 
circles) or TPA-treated platelets (closed symbols} were incubated for 
10 rain with different concentrations of epinephrine of PGE~ Results 
are presented as o7o of basal activities that were 18 z 3 and 15 -,- 3 
pmol, rain" ~ 'mg protein" for membranes from control and TPA- 
treated cells, respectively, Plotted are the means and vertical lines 
represent the SE of 10 experiments performed in triplicate. 
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Fig, 3, Effect of TPA on the pertussis toxin catalyzed ADP- 
ribosylation in membranes from control and TPA-trcated platelets. 
Membranes from control (lines I, 3, 5) or TPA-treated platelets (lines 
2, 4) were incubated under the conditions for [szPlADP-ribosylation 
ih the absence (lifie 5) ot ptesefiee (lines 1-4) 6f patios.sis toxin. The 
membranes were solubilized and either subjected to SDS-PAGE 
(lines 3--5) or immunoprecipitated using a Gi-specific antibody and 
the precipitate subjected to SDS.PAGE (lines 1, 2). The auto- 
radiogram is representative of 5, all with similar results. 
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membranes from TPA-Ireated platelets (he labeling 
was consistently decreased 30-50% (Fig, .~ 1. The label- 
ed protein was immunoprecipltated usir# an specific 
an(i.Gi antiserum (Fill. 3); in the Immanoprecipltation 
the decrease In labeling induced by the treatment with 
TPA was even clearer (Fig. 3). 
4. DISCUSSION 
The findings that activation of PgC in platelets 
blocks the hormonal inhibition of adenylate cyclase ac- 
tivity [2-61 but not that induced by Gpp(NH)p [5,61 in- 
dicated that the rece~tor/Gi interactions rather than 
the Gi/cyclase interactions were altered [6]. Further 
support for this interpretation was obtained in the 
binding studies [6]. Our current data are consistent with 
such an interpretation; they clearly show that the ¢ft'0ct 
of agents whose receptors activate the GTPase activity 
of Gi is markedly decreased. In contrast, the stimula- 
tion of GTPase activity induced by PGE~ (putatively 
via activation of Os) is not altered which is also consis- 
tent with the absence of effect of TPA on the activatory 
branch of adenylate cyclase [2-6], 
We did not observe any effect of the treatment with 
TPA on the basal GTPase activity. However, 'basal' 
GTPase activity probably is the result of GTP hydro- 
lysis by several G-proteins. Therefore, we cannot rule 
out a direct effect of the treatment on the hydrolytic ac- 
tivity of Gi. Nevertheless, a blockade of the GTPase ac- 
tivity would probably result in a tonic activation of this 
G-protein (as observed in Gs, ADP-ribosylated by 
cholera toxin [14]); this is not what is observed. 
Current ideas indicate that the hormonal activation 
of the GTPase activity of G-proteins is probably secon- 
dary to the stimulation of the GDP/GTP exchange pro- 
moted by their interaction with activated receptors [15]. 
The perturbation of the receptor/Gi Interaction [6] by 
the treatment with TPA could be responsible for the 
blockade of the hormonal inhibition of adenylate 
cyclase [2-6] and activation of the GTPase activity of 
Gi. 
It has been suggested that the C-termini of Ge~ 
subunits govern in part the interaction of G-proteins 
with receptors [16]. Using a panel of specific antibodies 
against this domain, Simonds et al. [13] were able to 
block the hormonal inhibition of adenylate cyclase and 
identified the G-protein involved in this effect as Gi2. 
Interestingly, the consensus ite for pertussis toxin- 
catalyzed ADP-ribosylation is located in the same do- 
main [17]. It is possible that the decreased labeling 
observed by us with TPA and previously by others 
using other agents [18] could be due, at least partially, 
FEBS LETTER.",; F¢l~r.~ry I,~,~1 
to a perturbatlon or file C.terminus (receptor.couplinlt 
domain) of Oil, Olher possibilities such as C.protein 
subunit dissociation, c~nnot be ruled out. 
The molecular basis of the alteration of 0~2 function 
remains to be determined. Althoulih in vitro ex- 
periments sugllested that PKC phosphoryiates Gi [31, 
recent evidence indicates that phorbol criers phos- 
phorylate a G-protein oilier than Gi [19]. It is in. 
tercstinB to note that it has been shown that TPA 
blocks 0i function in liver cells [201 and that this effect 
is associated with the phosphorylation of Gi or [20]; 
however, the blockade of Gi function observed in liver 
cells is differer~t o that observed in platele(s, i,e. the in- 
hibitory action of Ilydrolysis-resistant analogues of 
GTP is blocked [20], 
Aeknowledllemenl,t; The authors thank Ms Guadalu p= gamirex for 
typinll the manuscript, This researcll was partially supported by a 
grant rrom DGAPA (1N021889), 
REFERENCES 
It) Nishi~.uka, Y. (1986) Science 233. 305-312, 
[2] Jakcbs, K,H., Bauer, S. ~nd Wa(annbe, Y, (1985) Eur. J, 
Biod~m, 151.42S-430. 
[3l Knmda, T.. Gilman, A,G., Watnnabc. Y., Ba~,~r, 5, and 
Jakobs, K,H. (1985) Eur, J, Biachem, 151,431-437, 
[4] Watanabe, ¥,, Horn, F,, Bauer, S. and Jnkobs, K,H. (19115) 
FEBS Lett 192, 23-27, 
[5] Bauer, S, and Jakobs, R,H, (1986) FEBS Left. |9,L 43-46, 
[6] Garcia-S:linz, J,A. and Gt,ti~rrc~-Venegas, G, (1989) FEBS 
Lett, 257, 42"/-430. 
[7] Hoffman, B,B,, Michel, T, Brecnneman, T.B, and Lefkowitz, 
R,J, (1982) Endocrinology 110, 926-932. 
[8] Cassel, D, altd Selenger, Z, (1976) Biochim Biophys, Acta 452, 
538-551. 
[9] Aktories, K, and Jakobs, K,H, (19811FEBS Lctt, 130,235-238, 
[10] Lowry, O,H,, Rosenhrough, N,J., Farr, A,L. an~ Randal, R,J. 
(1951) J, Biol, Chore, 193,265-2"/5, 
[II] Garcia-S,'linz, J,A,, l-luerta-Bahena, M.E, and Malbon, C,C, 
(1989) Am, J, Physio], 256, C384-C389. 
[12] Garcia-Sitinz, J,A and Macias-Silva, M. (1990) Biochem. 
Biopl~ys, Res, Commun, (11~ press). 
[13] Simonds, W.F.. Goldsmith, P,K,, Coding, J., Unson, C,(.3, and 
Spiegel, A.M, (1989) Proc, Natl. Acad. Sci. USA 86, 
7809-7813 
[14] Cassel. D, and Setinger, Z, (1977) Proc. Nail, Acad. Sci, USA 
75, 4155-4159. 
[15] Gilman, A (1987) Annu. Rev, Bioehem, $6, 615-649. 
[16] Masters, S.B,, Stroud, R,M, and Bourne, H,R. (1986) Protein 
Eng. 1, 47-54. 
[17] West, R,E.  Moss, J,, Vaughan, M., Liu, T. and Liu, T.Y. 
(1985) J, Biol. Chem, 260. 11428-11430. 
[18] Lapetina, E.G,, Reep, B, and Chang, K-J. (1986) Proc. Natl. 
Acad. Set. USA 83, 5880-5883 
[19] Carlson, K.E., Brass, L,F and Manning, D.R. (1989) J. Biol, 
Chem, 264, 13298-13305. 
[20] Pyne, N,J., Murphy, G,J,. Milligan, G. and Houslay, M.D. 
(1989) FEBS Lett, 243, "/7-82, 
318 
